Aclaris Therapeutics (ACRS) Reports In-Line Q4 EPS, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/2/2026

1. NKE
2. SPY
3. ACN
4. USO
5. NVDA
6. TRU
7. TLT
8. TSLA
9. ON
10. WBD

Go back to Aclaris Therapeutics (ACRS) Reports In-Line Q4 EPS, Revenues Beat
(NASDAQ: ACRS) Delayed: 4.51 +0.10 (2.27%)
Previous Close $4.41    52 Week High $33.88 
Open $4.44    52 Week Low $14.12 
Day High $4.52    P/E N/A 
Day Low $4.37    EPS $0.00 
Volume 505,052